Improving chemotherapy for patients with advanced non-small cell lung cancer
{{output}}
Introduction: Lung cancer is the third most common mortal disease in industrialised countries and the prognosis has been slow to improve. The largest subgroup has locally advanced or metastatic non-small cell lung cancer (NSCLC).... ...
